Results 81 to 90 of about 2,606,163 (178)

Occupational Hearing Loss in the Intensive Care Unit: A Comparative Study Between ICU and Non‐ICU Nursing Staff

open access: yesNursing in Critical Care, Volume 31, Issue 6, November 2026.
ABSTRACT Background Occupational exposure to sustained high‐noise levels in intensive care units (ICUs) could pose significant auditory health risks for healthcare professionals. Aim This investigation evaluates the prevalence and characteristics of hearing impairment among nursing staff working in an intensive care unit (ICU) versus non‐ICU ...
Ziwei Song   +3 more
wiley   +1 more source

Pattern of Ototoxicity in a Nigerian Teaching Hospital [PDF]

open access: yes, 2010
Ototoxicity is a preventable cause of irreversible sensorineural hearing loss. This paper aims to highlight the pattern of ototoxicity seen in a tertiary health institution. A retrospective study of patients with ototoxicity seen over a seven year period
A.D Salisu   +3 more
core   +1 more source

Automated technology for ototoxicity monitoring (Konrad-Martin et al., 2021)

open access: yes, 2021
Purpose: Determine the efficacy of ototoxicity monitoring (OM) administered as automated protocols with the Oto-ID mobile audiometer (automated ototoxicity monitoring [A-OM]), compared with usual care (UC) OM in cancer patients receiving cisplatin.Method:
Keri O’Connell Bennett (11458508)   +3 more
core   +1 more source

Ovarian Sex Cord Stromal Tumors in Children and Adolescents—The European Standard Clinical Practice Recommendations

open access: yesPediatric Blood &Cancer, Volume 73, Issue S4, October 2026.
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider   +15 more
wiley   +1 more source

Ototoxicity Associated with Oxaliplatin in a Patient with Pancreatic Cancer [PDF]

open access: yes, 2013
Context Oxaliplatin, a third-generation platinum derivative is commonly used for the treatment of colorectal cancer, pancreatic cancer, upper gastrointestinal cancer, hepatobiliary cancer, and ovarian cancer.
Rodriguez, Gladys   +4 more
core   +1 more source

Risk versus benefit: Who assesses this in the management of patients on ototoxic drugs?

open access: yesJournal of Pharmacy and Bioallied Sciences, 2017
The current paper is an attempt at highlighting important strategic indicators, as well as important variables, that the audiology community needs to consider in order to play a more central role in pharmaco-vigilance as part of pharmaco-audiology ...
Katijah Khoza-Shangase
doaj   +1 more source

Monitoring cisplatin-induced ototoxicity. [PDF]

open access: yes, 2017
Introduction and objective: The ototoxic damage goes unnoticed to disabling levels, being justified to apply control for its early detection procedures, make it possible to a therapeutic change and if necessary, a speech and auditory rehabilitation.
José Ignacio BENITO-OREJAS   +11 more
core   +1 more source

Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy [PDF]

open access: yes, 2020
© 2019, The Author(s). Introduction: Ototoxicity associated with platinum-based chemotherapy is highly prevalent and can cause detrimental consequences among cancer survivors.
Prayuenyong, Pattarawadee   +1 more
core   +1 more source

Proteomic Signatures of Noise‐Induced Hearing Loss in the Mouse Cochlea

open access: yesCell Biology International, Volume 50, Issue 10, October 2026.
ABSTRACT Hearing loss affects over 1.5 billion people worldwide and has substantial social, educational, and economic consequences. Although genetic studies have identified numerous hearing‐loss‐associated genes, the molecular changes accompanying noise‐induced hearing loss (NIHL) remain incompletely understood.
Ana Carla Batissoco   +6 more
wiley   +1 more source

Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions

open access: yesB-ENT, 2014
Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions. Objective: Pure tone audiometry (PTA) is currently widely used to monitor ototoxicity, but this method is timeconsuming.
M. K. Md Daud   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy